Cargando…
A randomized controlled trial of a therapeutic relational agent for reducing substance misuse during the COVID-19 pandemic
BACKGROUND: The COVID-19 pandemic disrupted access to treatment for substance use disorders (SUDs), while alcohol and cannabis retail sales increased. During the pandemic, we tested a tailored digital health solution, Woebot-SUDs (W-SUDs), for reducing substance misuse. METHODS: In a randomized cont...
Autores principales: | Prochaska, Judith J., Vogel, Erin A., Chieng, Amy, Baiocchi, Michael, Maglalang, Dale Dagar, Pajarito, Sarah, Weingardt, Kenneth R., Darcy, Alison, Robinson, Athena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423936/ https://www.ncbi.nlm.nih.gov/pubmed/34507061 http://dx.doi.org/10.1016/j.drugalcdep.2021.108986 |
Ejemplares similares
-
A Therapeutic Relational Agent for Reducing Problematic Substance Use (Woebot): Development and Usability Study
por: Prochaska, Judith J, et al.
Publicado: (2021) -
Associations with E-cigarette use among Asian American and Pacific Islander young adults in California
por: Maglalang, Dale Dagar, et al.
Publicado: (2016) -
Perceived Discrimination and Psychological Distress: A Survey of Filipinx Americans in Massachusetts during the COVID-19 Pandemic
por: Maglalang, Dale Dagar, et al.
Publicado: (2021) -
Correlates of smoking during COVID-19 in the LGBTQI + cancer survivor population
por: Maglalang, Dale Dagar, et al.
Publicado: (2023) -
Socioeconomic status across the life course and smoking trajectories of older adult smokers in the U.S.
por: Avila, Jaqueline, et al.
Publicado: (2021)